Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
Hepatitis B virus (HBV) chronic infection affects up to 240 million people in the world and it is a common cause of cirrhosis and hepatocellular carcinoma (HCC). HBV covalently closed circular DNA (cccDNA) pla...